United States
Germany
Japan
United Kingdom
China
MAPK1 (untagged)-Kinase deficient mutant (K54M) of Human mitogen-activated protein kinase 1 (MAPK1), transcript variant 2
| Type | Human Untagged Clone |
| Tag | Tag Free |
| Vector | pCMV6-XL5 |
Products
Anti-MAPK1 (ERK2) mouse monoclonal antibody, clone OTI1C11 (formerly 1C11)
| Applications | IP, WB |
| Reactivities | Human, Mouse, Rat |
ERK2 (MAPK1) (N-term) rabbit polyclonal antibody, Aff - Purified
| Applications | WB |
| Reactivities | Human, Mouse, Rat |
Recombinant Human Mitogen-activated protein kinase 1/MAPK1
| Tag | C-His |
Transient overexpression of MAPK1, transcript variant 2, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
Transient overexpression of MAPK1, transcript variant 1, in HEK293T cells, FFPE control for IHC, ICC and ISH staining, 25 slides per pack
活动过滤器
优化搜索结果
Species
Reactivities
Antibody Hosts
Expression Hosts
Lentivirus
Tags
Vectors
Knockout (KO) Validation
Conjugates
Modifications
Isotypes
Clonalities
Assay Types
QC Levels
Pathways
- Acute myeloid leukemia (96)
- Adherens junction (96)
- Alzheimer's disease (96)
- Axon guidance (96)
- B cell receptor signaling pathway (96)
- Bladder cancer (96)
- Chemokine signaling pathway (96)
- Chronic myeloid leukemia (96)
- Colorectal cancer (96)
- Dorso-ventral axis formation (96)
- Endometrial cancer (96)
- ErbB signaling pathway (96)
- Fc epsilon RI signaling pathway (96)
- Fc gamma R-mediated phagocytosis (96)
- Focal adhesion (96)
- Gap junction (96)
- Glioma (96)
- GnRH signaling pathway (96)
- Insulin signaling pathway (96)
- Long-term depression (96)
- Long-term potentiation (96)
- MAPK signaling pathway (96)
- Melanogenesis (96)
- Melanoma (96)
- NOD-like receptor signaling pathway (96)
- Natural killer cell mediated cytotoxicity (96)
- Neurotrophin signaling pathway (96)
- Non-small cell lung cancer (96)
- Oocyte meiosis (96)
- Pancreatic cancer (96)
- Pathways in cancer (96)
- Prion diseases (96)
- Progesterone-mediated oocyte maturation (96)
- Prostate cancer (96)
- Regulation of actin cytoskeleton (96)
- Renal cell carcinoma (96)
- T cell receptor signaling pathway (96)
- TGF-beta signaling pathway (96)
- Thyroid cancer (96)
- Toll-like receptor signaling pathway (96)
- Type II diabetes mellitus (96)
- VEGF signaling pathway (96)
- Vascular smooth muscle contraction (96)
- mTOR signaling pathway (96)
